Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Pricing
Privacy PolicyTerms of Service

DXR

$10.84+3.63%

DAXOR CORP

Market Cap
$44M
Sector
Health Care
Industry
Health Care
Beta
0.38
5yr monthly vs SPY
Price Chart
Loading…

Signals

Insider Velocity
25.6x
buying
Congress
—
recent trades
Short Volume
53%
W/W -10.1pp

Market & Alt Data

News
8
recent articles
Activist
—
none active
Analyst Consensus
Strong Buy
6 analysts
Velocity Score
25.65x
Current Rate (90d)
88.23/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
3
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-04-082026-04-10Feldschuh Michael RichardDirector & Chief Executive OfficerPurchase1,000$9.07$9K213.7KView
2026-03-312026-03-31Michel Robert JChief Financial OfficerPurchase1,000$9.90$10K21.1KView
2026-03-202026-03-24Jefferies JohnChief Medical OfficerPurchase5,941$0.00—23.6KView

Recent News

Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
Yahoo Finance · 2026-09-08
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
Yahoo Finance · 2026-09-01
Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas
Yahoo Finance · 2026-07-30
Dynamic announces July 2026 cash distributions for Dynamic Active ETFs and ETF Series
Yahoo Finance · 2026-07-21

Informational purposes only, not investment advice.

Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas
Yahoo Finance · 2026-07-07
Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor
Yahoo Finance · 2026-06-02
Dynamic announces May 2026 cash distributions for Dynamic Active ETFs and ETF Series
Yahoo Finance · 2026-05-19
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
Yahoo Finance · 2026-04-28

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →